Dallah Healthcare CoSAU:4004 -0.90%91 OCF Margin % is 10.11% as of Mar. 2026, which is 48% below its 10-year median of 19.47. GuruFocus rates SAU:4004 with a GF Score™ of 91/100 and a GF Value™ of ﷼204.73 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Dallah Healthcare Co ranks better than 52.03% on this metric.
The historical rank and industry rank for Dallah Healthcare Co's OCF Margin % or its related term are showing as below:
SAU:4004'
s OCF Margin % Range Over the Past 10 Years
Min: 13.66 Med: 19.47 Max: 29.53
Current: 9.04
During the past 13 years, the highest OCF Margin % of Dallah Healthcare Co was 29.53%. The lowest was 13.66%. And the median was 19.47%.
SAU:4004's OCF Margin % is ranked better than 52.03% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 8.27
vs SAU:4004: 9.04
Dallah Healthcare Co OCF Margin % Related Terms
Dallah Healthcare Co OCF Margin % Historical Data
* Premium members only.
The historical data trend for Dallah Healthcare Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4004 vs HCA, THC, DVA: OCF Margin % Comparison
For the Medical Care Facilities subindustry, Dallah Healthcare Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dallah Healthcare Co OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Dallah Healthcare Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dallah Healthcare Co (SAU:4004) has a OCF Margin % of 10.11% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Dallah Healthcare Co and its competitors. This is 48% below median its historical median of 19.47. Over the past decade, Dallah Healthcare Co's OCF Margin % has ranged from 13.66 to 29.53. According to the industry distribution chart, Dallah Healthcare Co ranks #319 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 48%.
Is Dallah Healthcare Co's OCF Margin % too high?
Dallah Healthcare Co's current OCF Margin % of 10.11% is 48% below median its 10-year median of 19.47. Over the past 10 years, this metric has ranged from a low of 13.66 to a high of 29.53. The Healthcare Providers & Services industry median OCF Margin % is 8.27. Dallah Healthcare Co's value of 10.11% is 22.2% above this industry median. Based on the distribution chart, Dallah Healthcare Co ranks #319 out of 665 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dallah Healthcare Co has a GF Score™ of 91/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's OCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dallah Healthcare Co ranks #319 out of 665 companies for OCF Margin %. This puts Dallah Healthcare Co in the upper half of its industry. The industry median OCF Margin % is 8.27. Dallah Healthcare Co's value of 10.11% is 22.2% above this benchmark. Historically, Dallah Healthcare Co's own OCF Margin % has ranged from 13.66 to 29.53 over the past decade. While the company's 10-year median is 19.47 vs. the industry median of 8.27, Dallah Healthcare Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.27, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dallah Healthcare Co's current OCF Margin % of 10.11% is 22.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Dallah Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dallah Healthcare Co's current OCF Margin % is 10.11%, which is 48% below median its own 10-year median of 19.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼204.73, compared to a current price of ﷼110.00 — trading 46.3% below its estimated fair value. The current OCF Margin % is 10.11%, which is 48% below median its 10-year median of 19.47 and 22.2% above the Healthcare Providers & Services industry median of 8.27. Dallah Healthcare Co's overall GF Score™ is 91/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current OCF Margin % is 10.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?
Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued.
The current stock price of ﷼110.00 is trading 46.3% below its estimated GF Value™ of ﷼204.73.
GuruFocus considers Dallah Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4004:
OCF Margin %: 10.11% (48% below median its 10-year median of 19.47)
GF Value™: ﷼204.73 vs. price of ﷼110.00 (46.3% below fair value)
Industry Position: 22.2% above the Healthcare Providers & Services median (#319 of 665)
No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
91GF Score
Get the complete analysis for SAU:4004
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4004 has been successfully added to your 
